Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-EPHA1 Antibody (R3F91)

Catalog #:   RHD47001 Specific References (31) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IHC, WB
Accession: P21709
Overview

Catalog No.

RHD47001

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IHC: 1:200-1:1000, WB: 1:500-1:2000

Target

Tyrosine-protein kinase receptor EPH, EPHT1, Erythropoietin-producing hepatoma receptor, hEpha1, EPH, EPHA1, Ephrin type-A receptor 1, EPH tyrosine kinase 1, EPH tyrosine kinase, EPHT

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P21709

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3F91

Data Image
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human ovary carcinoma (left) and breast carcinoma (right), showing cytoplasmic localization using EphA1 mouse mAb with DAB staining.
  • Western blot
    Western blot analysis using EphA1 mouse mAb against A549 (1) and Hela (2) cell lysate.
References

Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairs., PMID:36806315

Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains., PMID:34508727

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease., PMID:32296418

Inhibition of EphA/Ephrin-A signaling using genetic and pharmacologic approaches improves recovery following traumatic brain injury in mice., PMID:31319723

Serum biomarker panels for the diagnosis of gastric cancer., PMID:30873760

A potential role for Eph receptor signalling during migration of corneal endothelial cells., PMID:29476773

Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist., PMID:28747680

EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells., PMID:28560458

Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab., PMID:26854735

Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas., PMID:26261568

ADAM12-cleaved ephrin-A1 contributes to lung metastasis., PMID:23686306

Evaluation of Eph receptor and ephrin expression within the human cornea and limbus., PMID:23247085

The protection of acetylcholinesterase inhibitor on β-amyloid-induced the injury of neurite outgrowth via regulating axon guidance related genes expression in neuronal cells., PMID:23119107

Targeting of EPH receptor tyrosine kinases for anticancer therapy., PMID:22471709

Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System., PMID:22254144

Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis., PMID:21852108

EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell lines., PMID:21795402

Sesamin induces autophagy in colon cancer cells by reducing tyrosine phosphorylation of EphA1 and EphB2., PMID:21503576

Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice., PMID:21282286

[Neuronal identity and axonal projection of olfactory sensory neurons]., PMID:17552283

Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas., PMID:17525654

Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP., PMID:16925574

Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR., PMID:16325507

EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis., PMID:15154674

Identification of tyrosine kinases overexpressed in head and neck cancer., PMID:15023838

Identification of NPM-ALK interacting proteins by tandem mass spectrometry., PMID:14968112

Ephrin-A1 suppresses Th2 cell activation and provides a regulatory link to lung epithelial cells., PMID:14707054

EphA4 provides repulsive signals to developing cochlear ganglion neurites mediated through ephrin-B2 and -B3., PMID:12761826

Topographic-specific axon branching controlled by ephrin-As is the critical event in retinotectal map development., PMID:11606643

Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner., PMID:11032807

PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization., PMID:10660600

Datasheet

Document Download

Anti-EPHA1 Antibody (R3F91).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-EPHA1 Antibody (R3F91) [RHD47001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only